BRCA1 is phosphorylated at serine 1497 in vivo at a cyclin-dependent kinase 2 phosphorylation site

Molecular and Cellular Biology

Volumn 19, Issue 7, 1999, Pages 4843-4854

  Ruffner, Heinz ^a   Jiang, Wei ^a   Craig, A Grey ^a   Hunter, Tony ^a   Verma, Inder M ^a  

^a SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; CYCLIN A; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 2; UNCLASSIFIED DRUG;

ARTICLE; COMPLEX FORMATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; STRUCTURE ANALYSIS;

EID: 0032999336     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.19.7.4843     Document Type: Article

References (83)

1. Abel, K. J., J. Xu, G. Y. Yin, R. H. Lyons, M. H. Meisler, and B. L. Weber. 1995. Mouse Brca1: localization, sequence analysis and identification of evolutionarily conserved domains. Hum. Mol. Genet. 4:2265-2273.
2. Adams, P. D., W. R. Sellers, S. K. Sharma, A. D. Wu, C. M. Nalin, and W. G. Kaelin, Jr. 1996. Identification of a cyclin-cdk2 recognition motif present in substrates and p21-like cyclin-dependent kinase inhibitors. Mol. Cell. Biol. 16:6623-6633.
3. Anderson, S. F., B. P. Schlegel, T. Nakajima, E. S. Wolpin, and J. D. Parvin. 1998. BRCA1 protein is linked to the RNA polymerase II holoenzyme complex via RNA helicase A. Nat. Genet. 19:254-256.
4. Beijersbergen, R. L., and R. Bernards. 1996. Cell cycle regulation by the retinoblastoma family of growth inhibitory proteins. Biochim. Biophys. Acta 1287:103-120.
5. Bennett, L. M., H. A. Brownlee, S. Hagevik, A. Haugen-Strano, and R. W. Wiseman. 1996. Evolutionarily conserved domains of the rat BRCA1 protein. Proc. Annu. Meet. Am. Assoc. Cancer Res. 37:514-515.
6. Bork, P., K. Hoffmann, P. Bucher, A. F. Neuwald, S. F. Altschul, and E. V. Koonin. 1997. A superfamily of conserved domains in DNA damage-responsive cell cycle checkpoint proteins. FASEB J. 11:68-76.
7. Boyle, W. J., P. van der Geer, and T. Hunter. 1991. Phosphopeptide mapping and phosphoamino acid analysis by two-dimensional separation on thin-layer cellulose plates. Methods Enzymol. 201:110-149.
8. Breast cancer information core. 12 March 1999, revision date. www.nhgri .nih.gov/Intramural_research/Lab_transfer/bic/. [Online.] [5 May 1999, last date accessed.]
9. Burke, T. F., K. S. Cocke, S. J. Lemke, E. Angleton, G. W. Becker, and R. P. Beckmann. 1998. Identification of a BRCA1-associated kinase with potential biological relevance. Oncogene 16:1031-1040.
10. Callebaut, I., and J. P. Mornon. 1997. From BRCA1 to RAP1: a widespread BRCT module closely associated with DNA repair. FEBS Lett. 400:25-30.
11. Chapman, M. S., and I. M. Verma. 1996. Transcriptional activation by BRCA1. Nature 382:678-679.
12. Chen, C. F., S. Li, Y. Chen, P. L. Chen, Z. D. Sharp, and W. H. Lee. 1996. The nuclear localization sequences of the BRCA1 protein interact with the importin-alpha subunit of the nuclear transport signal receptor. J. Biol. Chem. 271:32863-32868.
13. Chen, J., D. P. Silver, D. Walpila, S. B. Cantor, A. F. Gazdar, G. Tomlinson, F. J. Couch, B. L. Weber, T. Ashley, D. M. Livingston, and R. Scully. 1998 Stable interaction between the products of the BRCA1 and BRCA2 tumor suppressor genes in mitotic and meiotic cells. Mol. Cell 2:317-328.
14. Chen, Y., C. F. Chen, D. J. Riley, D. C. Allred, P. L. Chen, D. Von Hoff, C. K. Osborne, and W. H. Lee. 1995. Aberrant subcellular localization of BRCA1 in breast cancer. Science 270:789-791.
15. Chen, Y., P.-L. Chen, D. J. Riley, W.-H. Lee, D. C. Allred, and C. K. Osborne. 1996. Location of BRCA1 in human breast and ovarian cancer cells. Science 272:125-126.
16. Chen, Y., A. A. Farmer, C. F. Chen, D. C. Jones, P. L. Chen, and W. H. Lee. 1996. BRCA1 is a 220-kDa nuclear phosphoprotein that is expressed and phosphorylated in a cell cycle-dependent manner. Cancer Res. 56:3168-3172.
17. Claus, E., N. Risch, and W. Thompson. 1991. Genetic analysis of breast cancer in the cancer and steroid hormone study. Am. J. Hum. Genet. 48: 232-242.
18. Easton, D. F., D. T. Bishop, D. Ford, G. P. Crockford, and The Breast Cancer Linkage Consortium. 1993. Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. Am. J. Hum. Genet. 52:678-701.
19. Fisher, R. P. 1997. CDKs and cyclins in transition(s). Curr. Opin. Genet. Dev. 7:32-38.
20. Futreal, P. A., Q. Liu, D. Shattuck-Eidens, C. Cochran, K. Harshman, S. Tavtigian, L. M. Bennett, A. Haugen-Strano, J. Swensen, Y. Miki, et al. 1994. BRCA1 mutations in primary breast and ovarian carcinomas. Science 266: 120-122.
21. Garcia-Patino, E., B. Gomendio, M. Provencio, J. M. Silva, J. M. Garcia, P. Espana, and F. Bonilla. 1998. Germ-line BRCA1 mutations in women with sporadic breast cancer: clinical correlations. J. Clin. Oncol. 16:115-120.
22. Gottlieb, T. M., and M. Oren. 1996. p53 in growth control and neoplasia. Biochim. Biophys. Acta 1287:77-102.
23. Gowen, L. C., A. V. Avrutskaya, A. M. Latour, B. H. Koller, and S. A. Leadon. 1998. BRCA1 required for transcription-coupled repair of oxidative DNA damage. Science 281:1009-1012.
24. Gowen, L. C., B. L. Johnson, A. M. Latour, K. K. Sulik, and B. H. Koller. 1996. Brca1 deficiency results in early embryonic lethality characterized by neuroepithelial abnormalities. Nat. Genet. 12:191-194.
25. Greenman, J., S. Mohammed, D. Ellis, S. Watts, G. Scott, L. Izatt, D. Barnes, E. Solomon, S. Hodgson, and C. Mathew. 1998. Identification of missense and truncating mutations in the BRCA1 gene in sporadic and familial breast and ovarian cancer. Genes Chromosomes Cancer 21:244-249.
26. Grifman, M., and M. Weitzman (The Salk Institute). Unpublished data.
27. Gudas, J. M., T. Li, H. Nguyen, D. Jensen, F. J. Rauscher III, and K. H. Cowan. 1996. Cell cycle regulation of BRCA1 messenger RNA in human breast epithelial cells. Cell Growth Differ. 7:717-723.
28. Hakem, R., J. L. de la Pompa, C. Sirard, R. Mo, M. Woo, A. Hakem, A. Wakeham, J. Potter, A. Reitmair, F. Billia, E. Firpo, C. C. Hui, J. Roberts, J. Rossant, and T. W. Mak. 1996. The tumor suppressor gene Brca1 is required for embryonic cellular proliferation in the mouse. Cell 85:1009-1023.
29. Harper, J. W., and S. J. Elledge. 1996. Cdk inhibitors in development and cancer. Curr. Opin. Genet. Dev. 6:56-64.
30. Hunter, T., and J. Pines. 1994. Cyclins and cancer II: cyclin D and CDK inhibitors come of age. Cell 79:573-582.
31. Jiang, W. Unpublished data.
32. Jiang, W., G. Jimenez, N. J. Wells, T. J. Hope, G. M. Wahl, T. Hunter, and R. Fukunaga. 1998. PRC1: a human mitotic spindle-associated CDK substrate protein required for cytokinesis. Mol. Cell 2:877-885.
33. Kanemitsu, M. Y., W. Jiang, and W. Eckhart. 1998. Cdc2-mediated phosphorylation of the gap junction protein, connexin43, during mitosis. Cell Growth Differ. 9:13-21.
34. Kelsell, D. P., D. M. Black, D. T. Bishop, and N. K. Spurr. 1993. Genetic analysis of the BRCA1 region in a large breast/ovarian family: refinement of the minimal region containing BRCA1. Hum. Mol. Genet. 2:1823-1828.
35. Kelsell, D. P., N. K. Spurr, D. M. Barnes, B. Gusterson, and D. T. Bishop. 1996. Combined loss of BRCA1/BRCA2 in grade 3 breast carcinomas. Lancet 347:1554-1555.
36. Kerangueven, F., F. Eisinger, T. Noguchi, F. Allione, V. Wargniez, C. Eng, G. Padberg, C. Theillet, J. Jacquemier, M. Longy, H. Sobol, and D. Birnbaum. 1997. Loss of heterozygosity in human breast carcinomas in the ataxia telangiectasia, Cowden disease and BRCA1 gene regions. Oncogene 14:339-347.
37. Kinzler, K. W., and B. Vogelstein. 1997. Cancer-susceptibility genes. Gatekeepers and caretakers. Nature 386:761-763.
38. Koonin, E. V., S. F. Altschul, and P. Bork. 1996. BRCA1 protein products... functional motifs... Nat. Genet. 13:266-268.
39. Lane, T. F., C. Deng, A. Elson, M. S. Lyu, C. A. Kozak, and P. Leder. 1995. Expression of Brca1 is associated with terminal differentiation of ectodermally and mesodermally derived tissues in mice. Genes Dev. 9:2712-2722.
40. Langston, A. A., K. E. Malone, J. D. Thompson, J. R. Daling, and E. A. Ostrander. 1996. BRCA1 mutations in a population-based sample of young women with breast cancer. N. Engl. J. Med. 334:137-142.
41. Lees, E. 1995. Cyclin dependent kinase regulation. Curr. Opin. Cell Biol. 7:773-780.
42. Lewin, B. 1990. Driving the cell cycle: M phase kinase, its partners, and substrates. Cell 61:743-752.
43. Liu, C. Y., A. Flesken-Nikitin, S. Li, Y. Zeng, and W. H. Lee. 1996. Inactivation of the mouse Brca1 gene leads to failure in the morphogenesis of the egg cylinder in early postimplantation development. Genes Dev. 10:1835-1843.
44. Marquis, S. T., J. V. Rajan, A. Wynshaw-Boris, J. Xu, G. Y. Yin, K. J. Abel, B. L. Weber, and L. A. Chodosh. 1995. The developmental pattern of Brca1 expression implies a role in differentiation of the breast and other tissues. Nat. Genet. 11:17-26.
45. Meyer, L. 1996. Chemical inhibitors of cyclin-dependent kinases. Trends Cell Biol. 6:393-397.
46. Merajver, S. D., T. M. Pham, R. F. Caduff, M. Chen, E. L. Poy, K. A. Cooney, B. L. Weber, F. S. Collins, C. Johnston, and T. S. Frank. 1995. Somatic mutations in the BRCA1 gene in sporadic ovarian tumours. Nat, Genet. 9:439-443.
47. Mild, Y., J. Swensen, D. Shattuck-Eidens, P. A. Futreal, K. Harshman, S. Tavtigian, Q. Liu, C. Cochran, L. M. Bennett, W. Ding, et al. 1994. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266:66-71.
48. Monteiro, A. N., A. August, and H. Hanafusa. 1996. Evidence for a transcriptional activation function of BRCA1 C-terminal region. Proc. Natl. Acad. Sci. USA 93:13595-13599.
49. Neuhausen, S. L., and C. J. Marshall. 1994. Loss of heterozygosity in familial tumors from three BRCA1-linked kindreds. Cancer Res. 54:6069-6072.
50. cdc2 and its companion cyclin-dependent kinases. Trends Cell Biol. 3:296-301.
51. Nigg, E. A. 1995. Cyclin-dependent protein kinases: key regulators of the eukaryotic cell cycle. Bioessays 17:471-480.
52. Norbury, C., and P. Nurse. 1992. Animal cell cycles and their control. Annu. Rev. Biochem. 61:441-470.
53. Orend, G., T. Hunter, and E. Ruoslahti. 1998. Cytoplasmic displacement of cyclin E-cdk2 inhibitors p21Cip1 and p27Kip1 in anchorage-independent cells. Oncogene 16:2575-2583.
54. Ouchi, T., A. N. Monteiro, A. August, S. A. Aaronson, and H. Hanafusa. 1998. BRCA1 regulates p53-dependent gene expression. Proc. Natl. Acad. Sci. USA 95:2302-2306.
55. Ozcelik, H., M. D. To, J. Couture, S. B. Bull, and I. L. Andrulis. 1998. Preferential allelic expression can lead to reduced expression of BRCA1 in sporadic breast cancers. Int. J. Cancer 77:1-6.
56. Pao, G., R. Janknecht, H. Ruffner, T. Hunter, and I. M. Verma. CBP/p300 interact functionally with BRCA1 as transcriptional co-activators. Submitted for publication.
57. Papa, S., D. Seripa, G. Merla, C. Gravina, M. Giai, P. Sismondi, M. Rinaldi, A. Serra, G. Saglio, and V. M. Fazio. 1998. Identification of a possible somatic BRCA1 mutation affecting translation efficiency in an early-onset sporadic breast cancer patient. J. Natl. Cancer Inst. 90:1011-1012.
58. Pines, J. 1993. Cyclins and cyclin-dependent kinases: take your partners. Trends Biochem. Sci. 18:195-197.
59. Ruffner, H., and I. M. Verma. 1997. BRCA1 is a cell cycle-regulated nuclear phosphoprotein. Proc. Natl. Acad. Sci. USA 94:7138-7143.
60. Ruffner, H. Unpublished data.
61. Schulman, B. A., D. L. Lindstrom, and E. Harlow. 1998. Substrate recruitment to cyclin-dependent kinase 2 by a multipurpose docking site on cyclin A. Proc. Natl. Acad. Sci. USA 95:10453-10458.
62. Scully, R., S. F. Anderson, D. M. Chao, W. Wei, L. Ye, R. A. Young, D. M. Livingston, and J. D. Parvin. 1997. BRCA1 is a component of the RNA polymerase II holoenzyme. Proc. Natl. Acad. Sci. USA 94:5605-5610.
63. Scully, R., J. Chen, R. L. Ochs, K. Keegan, M. Hoekstra, J. Feunteun, and D. M. Livingston. 1997. Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage. Cell 90:425-435.
64. Scully, R., J. Chen, A. Plug, Y. Xiao, D. Weaver, J. Feunteun, T. Ashley, and D. M. Livingston. 1997. Association of BRCA1 with Rad51 in mitotic and meiotic cells. Cell 88:265-275.
65. Scully, R., S. Ganesan, M. Brown, J. A. De Caprio, S. A. Cannistra, J. Feunteun, S. Schnitt, and D. M. Livingston. 1996. Location of BRCA1 in human breast and ovarian cancer cells. Science 272:123-125.
66. Shao, N., Y. L. Chai, E. Shyam, P. Reddy, and V. N. Rao. 1996. Induction of apoptosis by the tumor suppressor protein BRCA1. Oncogene 13:1-7.
67. Somasundaram, K., H. Zhang, Y. X. Zeng, Y. Houvras, Y. Peng, G. S. Wu, J. D. Licht, B. L. Weber, and W. S. El-Deiry. 1997. Arrest of the cell cycle by the tumour-suppressor BRCA1 requires the CDK-inhibitor p21WAF1/CiP1. Nature 389:187-190.
68. Somia, N. Unpublished data.
69. Sourvinos, G., and D. A. Spandidos. 1998. Decreased BRCA1 expression levels may arrest the cell cycle through activation of p53 checkpoint in human sporadic breast tumors. Biochem. Biophys. Res. Commun. 245:75-80.
70. Szabo, C. I., L. A. Wagner, L. V. Francisco, J. C. Roach, R. Argonza, M. C. King, and E. A. Ostrander. 1996. Human, canine and murine BRCA1 genes: sequence comparison among species. Hum. Mol. Genet. 5:1289-1298.
71. Thakur, S., H. B. Zhang, Y. Peng, H. Le, B. Carroll, T. Ward, J. Yao, L. M. Farid, F. J. Couch, R. B. Wilson, and B. L. Weber. 1997. Localization of BRCA1 and a splice variant identifies the nuclear localization signal. Mol. Cell. Biol. 17:444-452.
72. Thomas, J. E., M. Smith, B. Rubinfeld, M. Gutowski, R. P. Beckmann, and P. Polakis. 1996. Subcellular localization and analysis of apparent 180-kDa and 220-kDa proteins of the breast cancer susceptibility gene, BRCA1. J. Biol. Chem. 271:28630-28635.
73. Thomas, J. E., M. Smith, J. L. Tonkinson, B. Rubinfeld, and P. Polakis. 1997. Induction of phosphorylation on BRCA1 during the cell cycle and after DNA damage. Cell Growth Differ. 8:801-809.
74. Thompson, M. E., R. A. Jensen, P. S. Obermiller, D. L. Page, and J. T. Holt. 1995. Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression. Nat. Genet. 9:444-450.
75. van den Heuvel, S., and E. Harlow. 1993. Distinct roles for cyclin-dependent kinases in cell cycle control. Science 262:2050-2054.
76. van der Geer, P., K. Luo, B. M. Sefton, and T. Hunter. 1994. Phosphopeptide mapping and phosphoamino acid analysis on cellulose thin-layer plates, p. 422-448. In J. E. Celis (ed.), Cell biology: a laboratory handbook. Academic Press, New York, N.Y.
77. Vaughn, J. P., P. L. Davis, M. D. Jarboe, G. Huper, A. C. Evans, R. W. Wiseman, A. Berchuck, J. D. Iglehart, P. A. Futreal, and J. R. Marks. 1996. BRCA1 expression is induced before DNA synthesis in both normal and tumor-derived breast cells. Cell Growth Differ. 7:711-715.
78. Wang, H., N. Shao, Q. M. Ding, J. Cui, E. S. Reddy, and V. N. Rao. 1997. BRCA1 proteins are transported to the nucleus in the absence of serum and splice variants BRCA1a, BRCA1b are tyrosine phosphoproteins that associate with E2F, cyclins and cyclin dependent kinases. Oncogene 15:143-157.
79. Wigler, M., A. Pellicer, S. Silverstein, R. Axel, G. Urlaub, and L. Chasin. 1979. DNA-mediated transfer of the adenine phosphoribosyltransferase locus into mammalian cells. Proc. Natl. Acad. Sci. USA 76:1373-1376.
80. Wilson, C. A., M. N. Payton, G. S. Elliott, F. W. Buaas, E. E. Cajulis, D. Grosshans, L. Ramos, D. M. Reese, D. J. Slamon, and F. J. Calzone. 1997. Differential subcellular localization, expression and biological toxicity of BRCA1 and the splice variant BRCA1-delta11b. Oncogene 14:1-16.
81. Wilson, C. A., L. Ramos, M. R. Villasenor, K. H. Anders, M. F. Press, K. Clarke, B. Karlan, J. J. Chen, R. Scully, D. Livingston, R. H. Zuch, M. H. Kanter, S. Cohen, F. J. Calzone, and D. J. Slamon. 1999. Localization of human BRCA1 and its loss in high-grade, non-inherited breast carcinomas. Nat. Genet. 21:236-240.
82. Zhang, H., K. Somasundaram, Y. Peng, H. Tian, D. Bi, B. L. Weber, and W. S. El-Deiry. 1998. BRCA1 physically associates with p53 and stimulates its transcriptional activity. Oncogene 16:1713-1721.
83. Zhang, H. T., X. Zhang, H. Z. Zhao, Y. Kajino, B. L. Weber, J. G. Davis, Q. Wang, D. M. O'Rourke, H. B. Zhang, K. Kajino, and M. I. Green. 1997. Relationship of p215BRCA1 to tyrosine kinase signaling pathways and the cell cycle in normal and transformed cells. Oncogene 14:2863-2869.